DESERT MOUNTAIN ENERGY CORP (DME.CA) Stock Fundamental Analysis
Canada - TSX Venture Exchange - TSX-V:DME - CA25043D1078 - Common Stock
0.35 CAD
-0.01 (-2.78%)
Overall DME gets a fundamental rating of 3 out of 10. We evaluated DME against 817 industry peers in the Metals & Mining industry. While DME seems to be doing ok healthwise, there are quite some concerns on its profitability. DME has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
- In the past year DME has reported negative net income.
- DME had a negative operating cash flow in the past year.
- In the past 5 years DME always reported negative net income.
- In the past 5 years DME always reported negative operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of -9.15%, DME is in the better half of the industry, outperforming 62.18% of the companies in the same industry.
- DME's Return On Equity of -9.80% is fine compared to the rest of the industry. DME outperforms 65.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.15% | ||
| ROE | -9.8% | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for DME so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- DME does not have a ROIC to compare to the WACC, probably because it is not profitable.
- DME has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- DME has an Altman-Z score of 4.18. This indicates that DME is financially healthy and has little risk of bankruptcy at the moment.
- DME has a Altman-Z score (4.18) which is in line with its industry peers.
- There is no outstanding debt for DME. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.18 |
ROIC/WACCN/A
WACC9.59%
2.3 Liquidity
- A Current Ratio of 2.00 indicates that DME should not have too much problems paying its short term obligations.
- DME has a Current ratio (2.00) which is comparable to the rest of the industry.
- DME has a Quick Ratio of 2.00. This is a normal value and indicates that DME is financially healthy and should not expect problems in meeting its short term obligations.
- With a Quick ratio value of 2.00, DME perfoms like the industry average, outperforming 53.98% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2 | ||
| Quick Ratio | 2 |
3. Growth
3.1 Past
- DME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.08%, which is quite impressive.
- The Revenue for DME has decreased by -50.66% in the past year. This is quite bad
EPS 1Y (TTM)63.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)-50.66%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-57.12%
3.2 Future
- The Earnings Per Share is expected to grow by 73.21% on average over the next years. This is a very strong growth
- Based on estimates for the next years, DME will show a very strong growth in Revenue. The Revenue will grow by 256.37% on average per year.
EPS Next Y60%
EPS Next 2Y73.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year310%
Revenue Next 2Y256.37%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
- DME reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- DME is valuated cheaply with a Price/Forward Earnings ratio of 6.80.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of DME indicates a rather cheap valuation: DME is cheaper than 96.45% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.30, DME is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 6.8 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as DME's earnings are expected to grow with 73.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y73.21%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- No dividends for DME!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX-V:DME (1/21/2026, 7:00:00 PM)
0.35
-0.01 (-2.78%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-27 2025-08-27/dmh
Earnings (Next)02-02 2026-02-02
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.71%
Ins Owner ChangeN/A
Market Cap33.14M
Revenue(TTM)860.30K
Net Income(TTM)-4.58M
Analysts84.44
Price Target0.51 (45.71%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-85.34%
Min Revenue beat(2)-94.84%
Max Revenue beat(2)-75.84%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 6.8 | ||
| P/S | 38.52 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.71 | ||
| P/tB | 0.71 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.05
EYN/A
EPS(NY)0.05
Fwd EY14.71%
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.01
BVpS0.49
TBVpS0.49
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.15% | ||
| ROE | -9.8% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | -27696.2% | ||
| Cap/Sales | 170.63% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2 | ||
| Quick Ratio | 2 | ||
| Altman-Z | 4.18 |
F-Score3
WACC9.59%
ROIC/WACCN/A
Cap/Depr(3y)5568.56%
Cap/Depr(5y)38613%
Cap/Sales(3y)1760.59%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y60%
EPS Next 2Y73.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-50.66%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-57.12%
Revenue Next Year310%
Revenue Next 2Y256.37%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y23.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year84.3%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y79.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.32%
OCF growth 3YN/A
OCF growth 5YN/A
DESERT MOUNTAIN ENERGY CORP / DME.CA FAQ
Can you provide the ChartMill fundamental rating for DESERT MOUNTAIN ENERGY CORP?
ChartMill assigns a fundamental rating of 3 / 10 to DME.CA.
What is the valuation status for DME stock?
ChartMill assigns a valuation rating of 4 / 10 to DESERT MOUNTAIN ENERGY CORP (DME.CA). This can be considered as Fairly Valued.
What is the profitability of DME stock?
DESERT MOUNTAIN ENERGY CORP (DME.CA) has a profitability rating of 1 / 10.
Can you provide the financial health for DME stock?
The financial health rating of DESERT MOUNTAIN ENERGY CORP (DME.CA) is 6 / 10.
What is the earnings growth outlook for DESERT MOUNTAIN ENERGY CORP?
The Earnings per Share (EPS) of DESERT MOUNTAIN ENERGY CORP (DME.CA) is expected to grow by 60% in the next year.